Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems.
about
Applied nanotoxicologyCatalytic Properties and Biomedical Applications of Cerium Oxide NanoparticlesThe effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticlesPharmacokinetic issues of imaging with nanoparticles: focusing on carbon nanotubes and quantum dotsNanoparticle Uptake: The Phagocyte ProblemPhysico-chemical properties based differential toxicity of graphene oxide/reduced graphene oxide in human lung cells mediated through oxidative stressEffect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticlesBiomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery.Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.Immune complement activation is attenuated by surface nanotopographyBiomedical applications of nanotechnology.Thermo-targeted drug delivery of geldanamycin to hyperthermic tumor margins with diblock elastin-based biopolymers.A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity.STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cellsDoxorubicin interactions with bovine serum albumin revealed by microdialysis with on-line laser-induced fluorescence detection at subpicogram level.ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles.Nanotechnology and the treatment of HIV infection.In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesImpact of carrier fluid composition on recovery of nanoparticles and proteins in flow field flow fractionation.High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties.Trehalose-Based Block Copolycations Promote Polyplex Stabilization for Lyophilization and in Vivo pDNA Delivery.Nanocarrier-based immunotherapy in cancer management and research.Protein bio-corona: critical issue in immune nanotoxicology.In vivo biodistribution of nanoparticles.Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects.A review of imaging methods for measuring drug release at nanometre scale: a case for drug delivery systems.Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules.The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.Surface tailoring of nanoparticles via mixed-charge monolayers and their biomedical applications.In vitro interaction of colloidal nanoparticles with mammalian cells: What have we learned thus far?Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages.Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.Advancing polymeric delivery systems amidst a nucleic acid therapy renaissance.HPMA-oligolysine copolymers for gene delivery: optimization of peptide length and polymer molecular weight.Effects of the protein corona on liposome-liposome and liposome-cell interactions.
P2860
Q23911868-9C1AD48F-C2D6-4654-B058-7DB45A8D72A1Q28383937-E9A4FE11-2D89-4159-A454-324C103F108DQ28386401-AFD222AD-0C34-463D-95A6-4EDCE0E5E983Q28388580-33435C5E-857D-45D2-BEA2-8D9AF512F4E8Q28395287-E9CDD099-CA6E-437E-9EE7-74EAF06062BDQ28396913-B1200237-2AB8-4F16-8237-8A113514F762Q28485162-5F888C3E-A7A3-4EA8-9700-240EAF76E6F3Q30369753-B38C67BF-D58D-411D-BFCD-9F6F525879CBQ30425859-47FBC9BA-CC64-4975-9EEF-94F9DF5B8B38Q30472780-EE59ECC6-C5B3-4554-AE99-5B3E4F31E107Q33659702-9DEED0E9-3750-45A4-9500-85101609E0ABQ33994250-F12E7939-3925-4DB4-A8AE-4FB5BA8419D0Q34454233-B36CE443-E6B6-4689-A050-41DCC2F13633Q34675068-B9D49161-7D20-459C-82B3-5F7D3ACAD7C3Q34763957-E3387BF4-FD36-45F4-A5A4-6D4A51DE527CQ35031755-5BD57C54-9BCB-45ED-A594-D4D62D26318CQ35586789-E26C5C54-1CE6-4A2C-BCC4-60232F9A1D5BQ35612858-590571DD-797C-4AEE-83A7-7977D200D8D7Q35839945-FA3FD38C-AD1A-410D-B330-4908AE2E187BQ35943647-20E02654-32C2-4D68-AD56-16362082743DQ36289257-D2072A1D-44F2-4EC9-A597-5D08B82A96D8Q36350272-FF1134AD-45B6-4BA1-BF68-A10544D00F5FQ36408332-3955F50A-96B2-4E66-945D-75B33B39EBBDQ36457147-B4691B87-3902-4EF2-88C1-D1559A522A01Q37031671-920AE422-32CC-4ED9-85B7-1E9E46A5E503Q37651354-48B9B74E-C253-4113-9208-8377837E2A44Q37906630-1A35346A-1772-4935-8C78-BCEC397C2BBDQ37955034-35A979C8-487C-41DA-BB6B-BD68328AE24BQ37974934-66B37E29-33D6-4A0F-AF56-5DC1D0884CC4Q37976494-12800D51-C196-4733-BA95-D0BEDFF55BD7Q38007992-A988E2D2-13D0-4F17-A6B0-9458DC500446Q38169195-7272CBD8-0B34-4942-85EE-CEA8033FDF87Q38176391-C3EBF218-119C-4568-BF19-25EB4FD54236Q38239933-D40D92E6-FBAE-457E-8204-F2907B95F9E0Q38253370-D34059CF-3C7B-46AD-9E40-C939BC4EDEEAQ38456643-0A9FB68A-E1F2-4550-9939-A24ABB86CB23Q38470559-D50ACB76-7AC5-4365-A649-8D08B70CA976Q38541348-8A79CE97-7426-477D-9994-F09D855BF266Q38741842-B82EF8DD-2C55-43B0-9491-A0412760E9A2Q38756510-46C6E31B-5C3F-4F94-B288-31B6261513C2
P2860
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interactions of nanoparticles ...... city of drug delivery systems.
@en
Interactions of nanoparticles ...... city of drug delivery systems.
@nl
type
label
Interactions of nanoparticles ...... city of drug delivery systems.
@en
Interactions of nanoparticles ...... city of drug delivery systems.
@nl
prefLabel
Interactions of nanoparticles ...... city of drug delivery systems.
@en
Interactions of nanoparticles ...... city of drug delivery systems.
@nl
P2860
P1476
Interactions of nanoparticles ...... city of drug delivery systems.
@en
P2093
Dmitri Simberg
Priya Prakash Karmali
P2860
P304
P356
10.1517/17425247.2011.554818
P407
P577
2011-02-04T00:00:00Z